Intermittent Fasting for Pancreatic Cancer Risk
What You Need to Know Before You Apply
What is the purpose of this trial?
To learn whether an eating pattern called intermittent fasting (IF) is tolerable and feasible for individuals at high risk of pancreatic cancer and whether IF is associated with changes in biological markers, including metabolic, inflammatory, microbiome, and imaging-related markers.
Who Is on the Research Team?
Florencia McAllister, MD
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants follow an intermittent fasting regimen, fasting for 16 consecutive hours each day with an 8-hour eating window
Follow-up
Participants are monitored for safety and effectiveness after treatment, including changes in biological markers
What Are the Treatments Tested in This Trial?
Interventions
- Intermittent Fasting
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Fast for 16 consecutive hours each day and have an 8-hour window for eating.
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.